"We're not in the genomic testing business, so it may not be as obvious to the casual observer that we have an important place in personalized medicine," explains Robert Reinhardt, MD, chief medical officer of ImmunoDiagnostics of Thermo Fisher Scientific (formerly Phadia). "Individuals are unique in terms of their sensitization patterns. More sophisticated testing technology in this area will have a positive impact on patients through personalized education, therapies, guidance and outcomes."
Molecular Allergy Testing Gets Personal
Art and Science of Laboratory Medicine
Web site: laboratoryeqas.exai.com